Advertisement

Repetitive transcranial magnetic stimulation for treatment of tardive syndromes: double randomized clinical trial

  • Eman M. Khedr
  • Bastawy Al Fawal
  • Ahmed Abdelwarith
  • Mostafa Saber
  • John C. Rothwell
Psychiatry and Preclinical Psychiatric Studies - Original Article

Abstract

Tardive syndromes (TDS) typically manifest 3 months or later after exposure to antipsychotic drugs, and unfortunately have no satisfactory medical treatment. We explored the possibility of using therapeutic repetitive transcranial magnetic stimulation (rTMS). Twenty-six patients were allocated to receive real or sham rTMS over the hand/arm area of motor cortex (M1). Each received a daily total of 2000 rTMS pulses (20 Hz at 100% rMT: 1000 stimuli per hemisphere) for 10 consecutive days. Outcome was assessed using the Abnormal Involuntary Movement Scale (AIMS) and TMS measures of M1 excitability. Three patients in the sham group failed to complete the study. At baseline, there was no significant difference between the groups in age, sex distribution, duration of illness, AIMS score and drug treatment. rTMS improved symptoms in both groups. However, there was a greater reduction in the AIMS score of the real rTMS group compared with the sham group (real, 8.3 ± 1.7 points; sham 1.2 ± 3.3; repeated measure analysis ANOVA Time X Group interaction P = 0.001). The same trends were observed in the clinical subscales. Following treatment, MEP amplitudes at higher intensities (140, and 150%) increased more in the real treatment group than in the sham group. This is the first clinical trial study of bilateral hemispheric rTMS in patients with TDS and suggests that 20 Hz rTMS might be a feasible treatment option in patients unresponsive to “first-line” treatment.

Clinical trial registration ClinicalTrials.gov Identifier: NCT03145311.

Keywords

rTMS Tardive syndromes Tardive dyskinesia Motor threshold Cortical excitability Drug induced extrapyramidal. 

Notes

Compliance with ethical standards

Conflict of interest

All authors have no conflict of interests and there was no fund.

References

  1. Aia PG, Revuelta GJ, Cloud LJ, Factor SA (2011) Tardive dyskinesia. Curr Treat Options Neurol 13:231–241CrossRefGoogle Scholar
  2. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Association, Arlington, p 712CrossRefGoogle Scholar
  3. Aquino CCH, Lang AE (2014) Tardive dyskinesia syndromes: current concepts. Parkinsonism Relat Disord 20:s113–7CrossRefGoogle Scholar
  4. Bhidayasiri R, Boonyawairoj S (2011) Spectrum of tardive syndromes: clinical recognition and management. Postgrad Med J 87(1024):132–141CrossRefGoogle Scholar
  5. Damier P, Thobois S, Witjas T, Cuny E, Derost P, Raoul S et al (2007) Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia. Arch Gen Psychiatry 64:170–176CrossRefGoogle Scholar
  6. Dauer WT, Fahn S, Burke RE (1998) The diagnosis and treatment of tardive disorders. Med Update Psychiatr 3:119–125CrossRefGoogle Scholar
  7. Franzini A, Marras C, Ferroli P, Zorzi G, Bugiani O, Romito L et al (2005) Long-term high-frequency bilateral pallidal stimulation for neuroleptic-induced tardive dystonia. Report of two cases. J Neurosurg 102:721–725CrossRefGoogle Scholar
  8. Guy W (1976) ECDEU Assessment Manual for Psychopharmacology: Revised (DHEW publication number ADM 76–338). Rockville, MD, US Department of Health, Education and Welfare, Public Health Service, Alcohol, Drug Abuse and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, pp 534–537Google Scholar
  9. Hauser RA, Factor SA, Marder SR, Knesevich MA, Ramirez PM, Jimenez R et al (2017) KINECT 3: a phase 3 randomized, double-blind, placebo-controlled trial of valbenazine for tardive dyskinesia. Am J Psychiatry 174(5):476–484CrossRefGoogle Scholar
  10. Khedr EM, Ahmed MA, Mohamed KA (2006a) Motor and visual cortical excitability in migraineurs patients with or without aura: transcranial magnetic stimulation. Clin Neurophysiol 36:13–18CrossRefGoogle Scholar
  11. Khedr EM, Rothwell JC, Shawky OA, Ahmed MA, Hamdy A (2006b) Effect of daily repetitive transcranial magnetic stimulation on motor performance in Parkinson’s disease. Mov Disord 21:2201–2205CrossRefGoogle Scholar
  12. Khedr EM, Abo-Elfetoh N, Elbeh KA, Baky AA, Gamal RM, El Hammady D, Korashy F (2015) Transcranial magnetic stimulation identifies cortical excitability changes in monosymptomatic nocturnal enuresis. Neurophysiol Clin 45(2):151–158CrossRefGoogle Scholar
  13. Khedr EM, Elbeh KA, Elserogy Y, Khalifa HE, Ahmed MA, Hafez MH, Ali AM, Elfetoh NA (2016a) Motor cortical excitability in obsessive-compulsive disorder: transcranial magnetic stimulation study. Neurophysiol Clin 46(2):135–143CrossRefGoogle Scholar
  14. Khedr EM, Gabra RH, Noaman M, Abo Elfetoh N, Farghaly HS (2016b) Cortical excitability in tramadol dependent patients: a transcranial magnetic stimulation study. Drug Alcohol Depend Dec 1:169:110–116CrossRefGoogle Scholar
  15. Lerner V, Miodownik C (2011) Motor symptoms of schizophrenia: is tardive dyskinesia a symptom or side effect? A modern treatment. Curr Psychiatry Rep 13(4):295–304 (Review) CrossRefGoogle Scholar
  16. Lomarev MP, Kanchana S, Bara-Jimenez W, Iyer M, Wassermann EM, Hallett M (2006) Placebo-controlled study of rTMS for the treatment of Parkinson’s disease. Mov Disord 21:325–331CrossRefGoogle Scholar
  17. Loonen AJ, Ivanova SA (2013) New insights into the mechanism of drug-induced dyskinesia. CNS Spectr 18(1):15–20CrossRefGoogle Scholar
  18. Nandi D, Parkin S, Scott R, Winter JL, Joint C, Gregory R, Stein J, Aziz TZ (2002) Camptocormia treated with bilateral pallidal stimulation. J Neurosurg 97(2):461–466CrossRefGoogle Scholar
  19. Pouclet-Courtemanche H, Rouaud T, Thobois S, Nguyen JM, Brefel-Courbon C, Chreau I et al (2016) Long-term efficacy and tolerability of bilateral pallidal stimulation to treat tardive yskinesia. Neurology 86:651–659CrossRefGoogle Scholar
  20. Sako W, Goto S, Shimazu H, Murase N, Matsuzaki K, Tamura T et al (2008) Bilateral deep brain stimulation of the globus pallidus internus in tardive dystonia. Mov Disord 23:1929–1931CrossRefGoogle Scholar
  21. Shaikh AG, Mewes K, Jinnah HA, DeLong MR, Gross RE, Triche S, Freeman A, Factor SA (2014) Globus pallidus deep brain stimulation for adult-onset axial dystonia. Parkinsonism Relat Disord 20(11):1279–1282CrossRefGoogle Scholar
  22. Sun B, Chen S, Zhan S, Le W, Krahl SE (2007) Subthalamic nucleus stimulation for primary dystonia and tardive dystonia. Acta Neurochir Suppl 97:207–214CrossRefGoogle Scholar
  23. Teo JT, Edwards MJ, Bhatia K (2012) Tardive dyskinesia is caused by maladaptive synaptic plasticity: a hypothesis. Mov Disord 27(10):1205–1215CrossRefGoogle Scholar
  24. Thobois S, Ballanger B, Xie-Brustolin J, Damier P, Durif F, Azulay JP, Derost P, Witjas T, Raoul S, Le Bars D, Broussolle E (2008) Globus pallidus stimulation reduces frontal hyperactivity in tardive dystonia. J Cereb Blood Flow Metab 28(6):1127–1138CrossRefGoogle Scholar
  25. Trottenberg T, Paul G, Meissner W, Maier-Hauff K, Taschner C, Kupsch A (2001) Pallidal and thalamic neurostimulation in severe tardive dystonia. J Neurol Neurosurg Psychiatry 70:557–559CrossRefGoogle Scholar
  26. Trugman JM, Leadbetter R, Zalis ME, Burgdorf RO, Wooten FG (1994) Treatment of severe axial tardive dystonia with clozapine: case report and hypothesis. Mov Disord 9:441–446CrossRefGoogle Scholar
  27. Tsai G, Goff DC, Chang RW, Flood J, Baer L, Coyle JT (1998) Makers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia. Am J Psychiatry 155:1207–1213CrossRefGoogle Scholar
  28. Werhahn KJ, Behrang-Nia M, Bott MC, Klimpe S (2007) Does the recruitment of excitation and inhibition in the motor cortex differ? J Clin Neurophysiol 24(5):419–423CrossRefGoogle Scholar
  29. Zhang JG, Zhang K, Wang ZC (2006) Deep brain stimulation in the treatment of tardive dystonia. Chin Med J 5:789–792Google Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2018

Authors and Affiliations

  • Eman M. Khedr
    • 1
    • 2
  • Bastawy Al Fawal
    • 2
  • Ahmed Abdelwarith
    • 2
  • Mostafa Saber
    • 2
  • John C. Rothwell
    • 3
  1. 1.Department of Neuropsychiatry, Faculty of Medicine, Assiut University HospitalAssiut UniversityAssuitEgypt
  2. 2.Department of Neuropsychiatry, Faculty of Medicine, Aswan University HospitalAswan UniversityAswanEgypt
  3. 3.Sobell Department of Motor Neuroscience and Movement DisordersNational Hospital for Neurology and NeurosurgeryLondonUK

Personalised recommendations